Post-Resuscitation ECG and Early Ablation After VF Arrest

Out-of-hospital cardiac arrest caused by ventricular fibrillation (VF) is a time-critical syndrome in which survival depends on rapid recognition, chest compressions, defibrillation and coordinated post-resuscitation care. Once spontaneous circulation returns, the electrocardiogram becomes a central diagnostic tool. It can reveal an acute coronary occlusion, suggest an inherited arrhythmia syndrome, or provide clues to a structural substrate that may require electrophysiological treatment.

For Australian clinicians, this pathway spans very different settings: a witnessed collapse in a Melbourne shopping centre, a long ambulance transfer in regional Queensland, or an arrest managed with support from the Royal Flying Doctor Service in a remote community. The priorities remain consistent, but access to emergency angiography, cardiac magnetic resonance imaging and specialist ablation teams varies considerably. A structured approach helps clinicians make safe decisions while the cause of VF is still being defined.

Reading the first ECG after return of circulation

The initial 12-lead ECG should be obtained as soon as practical after return of spontaneous circulation (ROSC), with repeat recordings when the patient’s haemodynamics, temperature or neurological status changes. ST-segment elevation or a new left bundle branch block may indicate acute coronary occlusion, although post-arrest myocardial stunning, catecholamine exposure and transient repolarisation changes can complicate interpretation.

An ECG without clear ST elevation does not exclude an ischaemic mechanism. Dynamic ST-T changes, recurrent ventricular ectopy, prolonged QT, Brugada-pattern abnormalities and epsilon-like or terminal depolarisation features may emerge during the first hours of intensive care. Serial ECGs are particularly important when the first tracing is recorded during shock, hypoxia, acidosis or targeted temperature management.

The tracing should be interpreted alongside the circumstances of the arrest. Chest pain before collapse, a family history of sudden death, exercise-related symptoms, medication exposure and the rhythm documented by an automated external defibrillator can narrow the differential diagnosis. In Australia, information from paramedics, bystanders and ambulance monitor downloads may be especially valuable when the patient arrives at a non-tertiary hospital far from an electrophysiology service.

Finding the cause beyond coronary occlusion

Urgent coronary angiography is indicated when the clinical and ECG findings suggest an acute coronary syndrome, and it remains essential for selected patients without ST elevation when there is cardiogenic shock, recurrent ventricular arrhythmia or a high suspicion of an occluded vessel. However, VF arrest can arise from myocarditis, cardiomyopathy, electrolyte disturbance, pulmonary embolism, hypoxia, drug toxicity and inherited electrical disease.

Echocardiography provides a rapid assessment of left and right ventricular function, regional wall motion, valve disease and mechanical complications. Cardiac magnetic resonance imaging can later identify infarction, oedema, fibrosis or an arrhythmogenic cardiomyopathy pattern. Coronary computed tomography may have a role in carefully selected patients, particularly when invasive angiography is unlikely to provide a diagnosis.

Laboratory testing should include potassium, magnesium, calcium, glucose, renal function, blood gas analysis and a toxicology review when appropriate. A markedly prolonged QT may be acquired, congenital or a combination of both. Sodium-channel blocker exposure, stimulant use and some psychotropic medicines should be considered before assigning the arrest to an unexplained or idiopathic category.

When early ablation becomes relevant

Catheter ablation is not a substitute for immediate resuscitation, coronary reperfusion or correction of reversible triggers. Its role becomes more urgent when VF or polymorphic ventricular tachycardia recurs despite correction of ischaemia, electrolyte abnormalities, hypoxia and acidosis. Electrical storm, repeated implantable cardioverter-defibrillator shocks and haemodynamic deterioration may justify an accelerated referral to an advanced electrophysiology service.

The ablation target depends on the substrate. In a patient with prior myocardial infarction, scar-related ventricular tachycardia may be mapped and treated once the clinical state allows. In idiopathic VF, triggered ventricular ectopy arising from the Purkinje system or outflow tract can sometimes be eliminated. Patients with Brugada syndrome may require substrate modification in the right ventricular outflow tract when recurrent VF persists despite medical therapy.

Early intervention requires careful selection. Profound neurological injury, active sepsis, severe multiorgan failure or an unresolved systemic cause may alter the balance of benefit and procedural risk. Conversely, delaying specialist review can be hazardous when ventricular arrhythmia is recurrent and conventional antiarrhythmic therapy is failing. A multidisciplinary discussion involving intensive care, interventional cardiology, electrophysiology and neurology is often the most appropriate route.

Integrating defibrillation, medicines and devices

Amiodarone and lignocaine are used in the acute management of shock-refractory VF according to resuscitation protocols, but their effectiveness and adverse effects must be reassessed after ROSC. Beta-blockade may help suppress adrenergic ventricular arrhythmia in selected cases, while quinidine has a specialised role in some inherited arrhythmia syndromes. Correcting potassium and magnesium is frequently as important as escalating antiarrhythmic medication.

An implantable cardioverter-defibrillator (ICD) is generally considered for survivors whose arrest was not caused by a fully reversible factor and whose long-term risk of malignant ventricular arrhythmia remains substantial. The decision should incorporate ventricular function, scar burden, genetic diagnosis, recurrent arrhythmia, neurological recovery and the patient’s goals of care. Subcutaneous systems may be suitable for some patients without a pacing indication, while transvenous devices provide pacing and antitachycardia functions when needed.

In metropolitan Australia, referral may proceed quickly to an electrophysiology unit at a major centre such as Royal Melbourne Hospital, Westmead Hospital or Royal Adelaide Hospital. Patients from the Northern Territory, western New South Wales or far north Queensland may need stabilisation, telehealth consultation and retrieval planning before transfer. These practical realities should be included in the risk assessment rather than treated as administrative details.

Procedural planning and follow-up

Ablation after VF arrest should be guided by a clearly defined clinical question. Is the team treating a monomorphic ventricular tachycardia circuit, frequent initiating ectopy, a Brugada substrate or an inflammatory cardiomyopathy? Three-dimensional mapping, intracardiac echocardiography and haemodynamic support may be required, especially when ventricular function is poor or the arrhythmia is easily induced.

The procedural risk profile includes vascular injury, cardiac perforation, stroke, coronary damage, atrioventricular block and worsening heart failure. When left-sided access is required, transseptal puncture is an important part of procedural planning; evidence on iatrogenic septal defects helps place small post-procedural shunts in their appropriate clinical context. Imaging and follow-up should be tailored to the access route and the patient’s symptoms.

The evidence base for ablation continues to develop across different arrhythmia syndromes and ventricular substrates. Techniques used in atrial procedures may also inform broader discussions about tissue effects, imaging and procedural endpoints; serial imaging data on cryoballoon ablation illustrate how structural and functional outcomes can be followed beyond the immediate procedure. Such findings should not be directly extrapolated to ventricular ablation, but they reinforce the value of longitudinal assessment.

Building a survivor-centred care pathway

Neurological prognostication should be delayed until confounding effects from sedation, temperature management, seizures and metabolic disturbance have been addressed. Families need clear explanations about uncertainty, expected testing and the difference between early survival and meaningful recovery. Rehabilitation may involve cardiology, neurology, physiotherapy, occupational therapy, psychology and community services.

Before discharge, the care plan should address ICD education, wound review, driving restrictions, medication adherence, genetic counselling and emergency planning. Australian driving recommendations distinguish private and commercial licensing, and the required restriction period depends on the cause of arrest, treatment and recurrence risk. Patients should receive written advice that reflects current local guidance rather than informal assumptions.

Family screening is essential when the arrest remains unexplained or suggests an inherited condition. First-degree relatives may need ECG, exercise testing, echocardiography, ambulatory monitoring or genetic assessment through an inherited arrhythmia clinic. Registries, research studies and peer-reviewed educational resources can help clinicians keep pace with changing evidence; the journal’s special issues bring related work together across ablation, devices, electrophysiology and arrhythmia care.

Care after discharge must remain coordinated. A regional cardiologist, local general practitioner and metropolitan electrophysiologist may all contribute, with remote review reducing unnecessary travel for patients in rural and remote Australia. Clear escalation instructions for palpitations, syncope, ICD shocks or recurrent chest pain can shorten delays when a dangerous rhythm returns.

Clinicians managing survivors of VF arrest can use the Journal of Arrhythmia to examine current research, clinical reviews and procedural evidence relevant to post-resuscitation ECG interpretation and early ablation. Explore the linked resources, discuss complex cases within the multidisciplinary team, and apply the evidence thoughtfully to each patient’s substrate, recovery and access to care.